Long Non Coding RNA in Complications of Systemic Lupus
Not Applicable
- Conditions
- Complication in Systemic Lupus Erythematosus
- Interventions
- Other: blood sampling
- Registration Number
- NCT03185767
- Lead Sponsor
- Cairo University
- Brief Summary
the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- with systemic lupus
Exclusion Criteria
vasculitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control group blood sampling - SLE group blood sampling -
- Primary Outcome Measures
Name Time Method non coding RNA expression by real time PCR 1 year non coding RNA expression by real time PCR to evaluate thier role in lupus
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link lncRNA dysregulation to SLE complications in NCT03185767?
How does lncRNA profiling compare to traditional biomarkers in predicting SLE complication risk?
Which lncRNA biomarkers correlate with treatment response in SLE patients with organ-specific complications?
What adverse events are associated with lncRNA-targeted therapies in SLE clinical trials?
Are there combination therapies involving lncRNA modulators for SLE complications under investigation by Cairo University?
Trial Locations
- Locations (1)
Cairo University
🇪🇬Cairo, Egypt